Clinical trial
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895 · OrbusNeich, Industry · Completed
Key facts
| NCT number | NCT00349895 |
|---|---|
| Title | Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth |
| Official title | Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth. A Clinical, Multi-center, Prospective, Non-Randomized Study |
| Lead sponsor | OrbusNeich, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Coronary Artery Stenosis |
| Intervention type | Device |
| Interventions | Coronary stent implantation |
| Enrollment | 100 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2012 |
| First posted | Jul 10, 2006 |
| Last update posted | Apr 8, 2014 |
| Countries | Austria, Belgium, France, Germany, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: